Title: Kim SM, et al. Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy. Oncogenesis. 2016 Jul 18;5(7):e241.
1454288-88-0 | Rovazolac | AA01EOBM | MFCD31657370
1811510-56-1 | PF-06260933 | AA01EOGP | MFCD30532622
2121989-91-9 | GSK2850163 | AA01EOM3 | MFCD30491882
851667-96-4 | 12-azido-3,7,11-trimethyldodeca-2E,6E,10E,-trien-1-ol | AA01EOQR | MFCD18428017
216699-07-9 | 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-(1S,4R)-2-cyclopentene-1-methanolsulfate | AA01EP13
64778-82-1 | 6-methoxy-α-methyl-1,3-benzodioxole-5-ethanamine,monohydrochloride | AA01EPBH
1035072-16-2 | α-[(2-chloroacetyl)(3-chloro-4-methoxyphenyl)amino]-N-(2-phenylethyl)-2-thiopheneacetamide | AA01EPIA | MFCD03450805
388086-13-3 | N-[2-(2,4-dichlorophenyl)-5-benzoxazolyl]-benzeneacetamide | AA01EPNI | MFCD01839641
14935-61-6 | (17β)-4-chloro-17-hydroxy-17-methyl-androst-4-ene-3,11-dione | AA01EPUD
151341-77-4 | (3R,5bS,6S,7aR,13bS,13cR,15aS)-2,3,5b,6,7,7a,8,13,13b,13c,14,15-dodecahydro-5b,6-dihydroxy-2,2,13b,13c-tetramethyl-4H-3,15a-epoxy-1-benzoxepino[6',7':6,7]indeno[1,2-b]indol-4-one | AA01EQ4C